Correlation Between Unicycive Therapeutics and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Unicycive Therapeutics and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Reviva Pharmaceuticals.
Diversification Opportunities for Unicycive Therapeutics and Reviva Pharmaceuticals
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Unicycive and Reviva is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Reviva Pharmaceuticals
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.32 times more return on investment than Reviva Pharmaceuticals. However, Unicycive Therapeutics is 1.32 times more volatile than Reviva Pharmaceuticals Holdings. It trades about 0.04 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.01 per unit of risk. If you would invest 54.00 in Unicycive Therapeutics on November 5, 2024 and sell it today you would earn a total of 7.00 from holding Unicycive Therapeutics or generate 12.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Unicycive Therapeutics |
| Reviva Pharmaceuticals |
Unicycive Therapeutics and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Reviva Pharmaceuticals
The main advantage of trading using opposite Unicycive Therapeutics and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |